Cancer Genetics, Inc.

Cancer Genetics, Inc.

Cancer Genetics, Inc.

Overview
Date Founded

1999

Headquarters

201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070

Type of Company

Public

Employees (Worldwide)

168

Industries

Medical Products & Equipment
IT Consulting & Services
Medical Support Services
Hospitals & Patient Services
Biotechnology

Company Description

Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Contact Data
Trying to get in touch with decision makers at Cancer Genetics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer & President

Chief Financial Officer

Chief Commercial Officer

Group Medical Director & Vice President of Hematopathology

Director, Cytogenetics

Executive Vice President, Precision Medicine & BioPharma Solutions

Vice President, BioPharma Collaborations & Companion Diagnostics

Vice President of Clinical Affairs & Site Operations

President, Discovery & Early Development

Board of Directors

Consultant at Mayo Clinic - Arizona

Managing Partner & Portfolio Manager at C7 Advisors LLC

Director-Pharmacogenomics & Individualized at The University of North Carolina at Charlotte

Professor at Gerstner Sloan Kettering Graduate School of Biomedical Science

President at Clinical Research Center of Cape Cod, Inc.

Member, Board of Directors at Cancer Genetics, Inc.

Paths to Cancer Genetics, Inc.
Potential Connections via
Relationship Science
You
Cancer Genetics, Inc.
Recent Transactions
Details Hidden

Interpace Diagnostics Group, Inc. purchases Cancer Genetics, Inc. /BioPharma Business from Cancer Genetics, Inc.

Details Hidden

Cancer Genetics, Inc. issued . USD Common Stock

Details Hidden

Reprocell, Inc. purchases Cancer Genetics (India) Pvt Ltd. from Cancer Genetics, Inc.

Transaction Advisors
Auditor

Advised onCancer Genetics, Inc. issued Common Stock

Underwriter

Advised onCancer Genetics, Inc. issued Common Stock

Underwriter

Advised onCancer Genetics, Inc. issued Common Stock

Legal Advisor

Advised onCancer Genetics, Inc. issued Common Stock

Legal Advisor

Advised onCancer Genetics, Inc. issued Common Stock

Head of Investment Banking

Advised onCancer Genetics, Inc. issued Common Stock

Advisors & Consultants
Advisor

Chief Financial & Accounting Officer at Innovate Biopharmaceuticals, Inc.

Consultant

Chief Executive Officer & Director at Lantern Pharma, Inc.

Publicist

Vice President at Russo Partners LLC

Clients

GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

eFFECTOR Therapeutics, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA.

Key Stats and Financials As of 2018
Market Capitalization
$5.56M
Total Enterprise Value
$18.8M
Earnings Per Share
$-0.75
Revenue
$27.5M
Net Profit
$-20.4M
EBITDA
$-15.9M
EBITDAMargin
-57.98%
Total Debt
$12.3M
Total Equity
$6.8M
Enterprise Value Sales
0.68x
TEVNet Income
-0.92x
Debt TEV
0.66x
Investors
Details Hidden

Professor at Gerstner Sloan Kettering Graduate School of Biomedical Science

Details Hidden

Equity Dynamics focuses on early-stage venture capital investments in technology, medical and healthcare companies located in the US. The firm will participate as a lead investor but this is not a requirement. They will also participate in investments with other venture capital firms.

Details Hidden

MediGen Group provides seed and early-stage capital to new life sciences companies. The firm may fund proof-of-concept experiments and deal conceptualization. Companies should have large growing markets and strong intellectual property. They should also have defined regulatory paths to accelerate product development and mitigate FDA approval risk. MediGen seeks investments in companies with a clear path to monetization with substantial short-term value-creating milestones that allow for multiple exit opportunities and hedges against developmental setbacks

Suppliers
Cleveland Clinic Hospitals & Patient Services | CLEVELAND, OH

Cleveland Clinic operates multispecialty academic medical center and hospitals. It offers outpatient care, primary care, numerous subspecialties and numerous locations. The company was founded in 1921 and is headquartered in Cleveland, OH.

Government of the United States of America Holding Companies | Washington, DC

The Government of the United States of America is the federal government of the republic of fifty states that constitute the United States, as well as one capital district, and several other territories. The federal government is composed of three distinct branches: legislative, executive and judicial, whose powers are vested by the U.S. Constitution in the Congress, the President, and the federal courts, including the Supreme Court, respectively.

Stanford University Biotechnology | Palo Alto, CA

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Laboratory Corporation of America Holdings Medical Support Services - Burlington, NC

LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialized Centers of Excellence. Recognized for our innovation, quality, and customer convenience, LabCorp delivers timely, accurate results for improved patient care. With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp performs more than 1 million tests on more than 370,000 specimens each day. LabCorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and more than 30,000 employees nationwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH

OPKO Health, Inc. Pharmaceuticals - MIAMI, FL

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cancer Genetics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cancer Genetics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cancer Genetics, Inc..